These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 950631)

  • 1. Immunopathology of penicillamine-induced glomerular disease.
    Dische FE; Swinson DR; Hamilton EB; Parsons V
    J Rheumatol; 1976 Jun; 3(2):145-54. PubMed ID: 950631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunopathology of penicillamine-induced glomerular disease.
    Dische FE; Swinson DR; Hamilton EB; Parsons V
    J Rheumatol; 1984 Oct; 11(5):584-5. PubMed ID: 6392549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteinuria in D-penicillamine-treated rheumatoid arthritis.
    Crawhall JC
    J Rheumatol Suppl; 1981; 7():161-3. PubMed ID: 6939879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penicillamine nephropathy in rheumatoid arthritis. A clinical, pathological and immunological study.
    Bacon PA; Tribe CR; Mackenzie JC; Verrier-Jones J; Cumming RH; Amer B
    Q J Med; 1976 Oct; 45(180):661-84. PubMed ID: 1005658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bucillamine induces membranous glomerulonephritis.
    Nagahama K; Matsushita H; Hara M; Ubara Y; Hara S; Yamada A
    Am J Kidney Dis; 2002 Apr; 39(4):706-12. PubMed ID: 11920335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoglobulin A nephropathy.
    Zimmerman SW; Burkholder PM
    Arch Intern Med; 1975 Sep; 135(9):1217-23. PubMed ID: 1164123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of penicillamine on the kidney.
    Davison AM; Day AT; Golding JR; Thomson D
    Proc R Soc Med; 1977; 70 Suppl 3(Suppl 3):109-13. PubMed ID: 122655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Glomerulopathy due to D-penicillamine--clinical findings and renal biopsy].
    Brass H; Genth E; Hartl PW; Bauerdick H; Buss H; Lapp H; Heintz R
    Med Welt; 1976 Nov; 27(45):2151-3. PubMed ID: 994834
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatitis-B-associated glomerulonephritis: pathology, pathogenesis, and clinical course.
    Venkataseshan VS; Lieberman K; Kim DU; Thung SN; Dikman S; D'Agati V; Susin M; Valderrama E; Gauthier B; Prakash A
    Medicine (Baltimore); 1990 Jul; 69(4):200-16. PubMed ID: 2142748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal biopsy appearances in rheumatoid disease.
    Sellars L; Siamopoulos K; Wilkinson R; Leohapand T; Morley AR
    Clin Nephrol; 1983 Sep; 20(3):114-20. PubMed ID: 6627762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesangial proliferative glomerulonephritis with unusual intramembranous granular dense deposits.
    Mampaso F; Leyva-Cobián F; Martínez-Montero JC; Gonzalo A; Bellas C; Moneo I; Junquera E
    Clin Nephrol; 1983 Feb; 19(2):92-8. PubMed ID: 6188567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gold nephropathy: tissue analysis by X-ray fluorescent spectroscopy.
    Viol GW; Minielly JA; Bistricki T
    Arch Pathol Lab Med; 1977 Dec; 101(12):635-40. PubMed ID: 412488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Glomerulopathy in rheumatic patients due to penicillamine].
    Muller V; Krumhaar I; Schneider W; Ditscherlein G
    Allerg Immunol (Leipz); 1976; 22(3):291-5. PubMed ID: 139094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do mesangial immune complex deposits affect the renal prognosis in membranous glomerulonephritis?
    Davenport A; Maciver AG; Hall CL; MacKenzie JC
    Clin Nephrol; 1994 May; 41(5):271-6. PubMed ID: 8050206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between D-penicillamine--induced proteinuria and prior gold nephropathy.
    Billingsley LM; Stevens MB
    Johns Hopkins Med J; 1981 Feb; 148(2):64-7. PubMed ID: 7206401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glomerular podocytopathy in patients with systemic lupus erythematosus.
    Kraft SW; Schwartz MM; Korbet SM; Lewis EJ
    J Am Soc Nephrol; 2005 Jan; 16(1):175-9. PubMed ID: 15548564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesangial isolated C3 deposition in patients with recurrent or persistent hematuria.
    Orfila C; Pieraggi MT; Suc JM
    Lab Invest; 1980 Jul; 43(1):1-8. PubMed ID: 6993785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steroid-sensitive nephrotic syndrome associated with positive C1q immunofluorescence.
    Hashimoto S; Ogawa Y; Ishida T; Mochizuki T; Koike T; Sato H; Ueda T
    Clin Exp Nephrol; 2004 Sep; 8(3):266-9. PubMed ID: 15480906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic markers in rheumatoid arthritis relationship to toxicity from D-penicillamine.
    Stockman A; Zilko PJ; Major GA; Tait BD; Property DN; Mathews JD; Hannah MC; McCluskey J; Muirden KD
    J Rheumatol; 1986 Apr; 13(2):269-73. PubMed ID: 3459889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serious side effects with D-penicillamine therapy for Wilson's disease].
    Storch W; Lössner J; Ruchholtz U
    Psychiatr Neurol Med Psychol (Leipz); 1979 Sep; 31(9):531-8. PubMed ID: 161403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.